Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention - Clinical and Economic Impact of Standard versus Extended Duration

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention - Clinical and Economic Impact of Standard versus Extended Duration

Join a comprehensive research presentation exploring the clinical and economic implications of standard versus extended duration dual antiplatelet therapy following percutaneous coronary intervention. Led by Dr. George A. Wells, Director of the Cardiovascular Research Methods Centre at the University of Ottawa Heart Institute, this 46-minute weekly research rounds session delves into evidence-based findings and analysis of treatment durations, their effectiveness, and associated economic considerations in cardiovascular care management.